Quarter Period Consolidated Statement Of Comprehensive Income

Daito Pharmaceutical Co., Ltd. - Filing #7730500

Concept 2017-06-01 to
2017-11-30
2016-06-01 to
2016-11-30
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
1,572,047,000 JPY
1,408,988,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
104,746,000 JPY
-222,195,000 JPY
Foreign currency translation adjustment
60,445,000 JPY
-173,480,000 JPY
Remeasurements of defined benefit plans, net of tax
2,124,000 JPY
87,321,000 JPY
Other comprehensive income
167,316,000 JPY
-308,354,000 JPY
Comprehensive income
1,739,363,000 JPY
1,100,634,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
1,736,345,000 JPY
1,167,822,000 JPY
Comprehensive income attributable to non-controlling interests
3,018,000 JPY
-67,187,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.